Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-14-063575
Filing Date
2014-10-29
Accepted
2014-10-29 14:32:51
Documents
3
Effectiveness Date
2014-10-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A v392463_defa14a.htm DEFA14A 18968
2 GRAPHIC image_001.jpg GRAPHIC 3455
3 GRAPHIC image_002.jpg GRAPHIC 1357
  Complete submission text file 0001144204-14-063575.txt   27127
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33357 | Film No.: 141179681
SIC: 2836 Biological Products, (No Diagnostic Substances)